Malaria Treatment Market Value and CAGR
Malaria is a serious fatal disease caused by a parasite that is transmitted to humans via mosquito bites. Malaria treatment is determined by the type and severity of the infection. The goal of treatment is to remove the parasite from the body while also preventing or treating disease symptoms.
Access complete report- https://douglasinsights.com/malaria-treatment-market
The global malaria treatment market was valued at $720 million in 2019 and is expected to grow at a (CAGR) of 6.9% from 2020 to 2029. According to the report, various factors are driving the growth of the malaria treatment market, including increased government initiatives and funding for malaria control programs, rising malaria prevalence in developing countries, and the development of new and effective drugs to combat drug-resistant strains of the parasite.
Malaria Treatment Market Growth Drivers and Risks
Drivers:
Malaria prevalence is increasing, which is a driving factor. Malaria is a potentially fatal disease caused by parasites that are transmitted to humans via the bites of infected mosquitos. The disease is widespread throughout the world, particularly in Sub-Saharan Africa, where it is a major public health issue. Malaria's rising prevalence is expected to drive up demand for malaria treatment.
Malaria awareness is growing: Governments and healthcare organizations are working to raise awareness about malaria and its prevention. As people become more aware of the disease and seek treatment, the demand for malaria treatment is expected to rise.
Risks:
Limited access to healthcare: Access to healthcare facilities is limited in many developing countries, which can impede malaria diagnosis and treatment.
Drug resistance: The emergence of drug-resistant strains of malaria poses a significant challenge to the disease's treatment. This can result in treatment failure and the need for additional therapies.
Malaria Treatment Market Keyplayers
By Company
- Zydus Healthcare Ltd
- Sun Pharmaceutical Industries Ltd
- Sanofi SA
- GSK Plc
- Novartis AG
Malaria Treatment Market Segmentations
By Treatment
- Prescription Medications
- Chloroquine Phosphate
- Artemisinin- based Combination Therapies (ACTs)
- Atovaquone-Proguanil
- Quinine Sulphate (Qualaquin) with Doxycycline
- Primaquine Phosphate
- Others
By Drug Type
- Branded
- Generics
By Route of Administration
- Oral
- Parenteral and Intravenous Mode
By Distribution Channel
- Direct Tender
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
By End User
- Hospitals
- Specialty Clinics
- Homecare
- Others
Table of content
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Malaria Treatment Market – By Treatment
1.3.2 Europe Malaria Treatment Market – By Drug Type
1.3.3 Europe Malaria Treatment Market – By Route of Administration
1.3.4 Europe Malaria Treatment Market – By Distribution Channel
1.3.5 Europe Malaria Treatment Market – By End User
1.3.6 Europe Malaria Treatment Market– By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Malaria Treatment Market– Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Malaria Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Government and Private Sector’s Initiatives to Raise Awareness About Malaria
5.2 Market Restraints
5.2.1 Counterfeit Antimalarial Drugs and Subsequent Drug Resistance
5.3 Market Opportunities
5.3.1 Extending Pipeline of New Drugs and Vaccines
5.4 Future Trends
5.4.1 Rapid Diagnostic Tests
5.5 Impact Analysis
6. Malaria Treatment Market– Europe Analysis
6.1 Europe Malaria Treatment Market Revenue Forecast and Analysis
7. Europe Malaria Treatment Market Analysis – By Treatment
7.1 Overview
7.2 Europe Malaria Treatment Market, By Treatment 2021 & 2028 (%)
7.3 Prescription Medications
7.3.1 Overview
7.3.2 Prescription Medication Market Revenue and Forecast to 2028 (US$ Mn)
7.3.3 Chloroquine Phosphate
7.3.3.1 Overview
7.3.3.2 Chloroquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
7.3.4 Artemisinin- based Combination Therapies (ACTs)
7.3.4.1 Overview
7.3.4.2 Artemisinin- based Combination Therapies (ACTs) Market Revenue and Forecast to 2028 (US$ Mn)
7.3.5 Atovaquone-Proguanil
7.3.5.1 Overview
7.3.5.2 Atovaquone-Proguanil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.6 Quinine Sulphate (Qualaquin) with Doxycycline
7.3.6.1 Overview
7.3.6.2 Quinine Sulphate (Qualaquin) with Doxycycline Market Revenue and Forecast to 2028 (US$ Mn)
7.3.7 Primaquine Phosphate
7.3.7.1 Overview
7.3.7.2 Primaquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
7.3.8 Others
7.3.8.1 Overview
7.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
7.4 Vaccines
7.4.1 Overview
7.4.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
7.5 Diagnostic Tests
7.5.1 Overview
7.5.2 Diagnostic Tests Market Revenue and Forecast to 2028 (US$ Mn)
7.6 Others
7.6.1 Overview
7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
8. Europe Malaria Treatment Market Analysis – By Drug Type
8.1 Overview
8.2 Europe Malaria Treatment Market, By Drug Type 2021 & 2028 (%)
8.3 Branded
8.3.1 Overview
8.3.2 Branded Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Generics
8.4.1 Overview
8.4.2 Generics Market Revenue and Forecast to 2028 (US$ Mn)
Toc Continue………………………..
For More Information Visit Our Website: https://douglasinsights.com/
Follow Douglas Insights for More Industry Updates- @ LinkedIn & Twitter
About Douglas Insights-
Douglas Insights UK limited is the first company to provide comparison of market research reports by Table of content, price, ratings and number of pages. We understand the value of time. Productivity and efficiency are possible when you take prompt and assured decisions. With our advanced algorithm, filters, and comparison engine, you can compare your preferred reports simultaneously, based on publisher rating, published date, price, and list of tables.
Office-
Bridge House, W Baldwin Rd,
Isle of Man IM4 5HA, Isle of Man
Email- isabella@douglasinsights.com
Telephone - +44 7624 248772
Web- douglasinsights.com/
